HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study

Increasing genetic diversity of HIV-1 and emergence of drug-resistant mutations may reduce the efficacy of antiretroviral therapy and prophylaxis that are used to prevent mother-to-child transmission. The aim of this study was to assess the genetic diversity and prevalence of drug-resistant mutation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:São Paulo medical journal 2018-03, Vol.136 (2), p.129-135
Hauptverfasser: Pimenta, Ana Teresa Mancini, Correa, Isadora Alonso, Melli, Patricia Pereira Dos Santos, Abduch, Renata, Duarte, Geraldo, Couto-Fernandez, José Carlos, Quintana, Silvana Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 135
container_issue 2
container_start_page 129
container_title São Paulo medical journal
container_volume 136
creator Pimenta, Ana Teresa Mancini
Correa, Isadora Alonso
Melli, Patricia Pereira Dos Santos
Abduch, Renata
Duarte, Geraldo
Couto-Fernandez, José Carlos
Quintana, Silvana Maria
description Increasing genetic diversity of HIV-1 and emergence of drug-resistant mutations may reduce the efficacy of antiretroviral therapy and prophylaxis that are used to prevent mother-to-child transmission. The aim of this study was to assess the genetic diversity and prevalence of drug-resistant mutations among HIV-infected pregnant women. Cross-sectional study at an outpatient clinic for infectious diseases within gynecology and obstetrics. This study evaluated the dynamics of HIV-1 subtypes and the prevalence of transmitted and acquired drug-resistant mutations among 38 HIV-infected pregnant women (20 previously exposed to antiretroviral therapy and 18 naive), in Ribeirão Preto (SP), Brazil, between 2010 and 2011. Genotyping was performed by means of molecular sequencing of the protease and reverse transcriptase regions of the HIV-1 pol gene. Subtype B was identified in 84.2% of the samples, recombinant forms between B and F in 7.9%, subtype F1 in 5.3% and the recombinant form K/F in 2.6%. No mutation associated with transmitted drug resistance was detected in the samples from the naive pregnant women, whereas mutations associated with acquired drug resistance were found in 35.0% of the pregnant women previously exposed to antiretroviral therapy. The results showed that subtype B predominated, while there was low prevalence of sequences with transmitted drug resistance.
doi_str_mv 10.1590/1516-3180.2017.0233011017
format Article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_scielo_journals_S1516_31802018000200129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1516_31802018000200129</scielo_id><doaj_id>oai_doaj_org_article_2f7b67489ddd4af7856f52bd4f6868a9</doaj_id><sourcerecordid>2043716431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3887-902cd4ac1528f545ea1618f1a3a2959ca75d63ec34044507eff449bb465c331e3</originalsourceid><addsrcrecordid>eNpFUltuFDEQHCEQCYErIPMXJGbxe-xPsiJkpUhEBPi1PHbPyqvZ8WLPBC1HyDU4ChfDwybLl1vlqmq7uqvqDcELIjR-TwSRNSMKLygmzQJTxjAhpXxSnRZU1ppL_LTUj7yT6kXOG4ypkoQ-r06objSRWJ1W91er7zVBaxhgDA75cAcph3GP7OBRghzyaAcHaIwFGUOCMcW7kGyPfJrWGdltHNZol2A9lHv0M25hQGFAX0ILIf35HdFN0UR0fnvz9h26SPZX6BdomWLOdQY3hjgUrzxOfv-yetbZPsOrh_Os-nb58evyqr7-_Gm1_HBdO6ZUU2tMnefWEUFVJ7gASyRRHbHMUi20s43wkoFjHHMucANdx7luWy6FY4wAO6tWB18f7cbsUtjatDfRBvMPiGltbCph9GBo17Sy4Up7X1p2jRKyE7T1vJNKKquL1-LglV2APppNnFL5UDa3c_Zmzr6MSOESPcaEzoLzg2CX4o8J8mi2ITvoeztAnLKhmLOGSM5IoeoD1c1pJeiObyXYzHtgjj3MvAfm_x4U7euHNlO7BX9UPg6e_QXzRqv-</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2043716431</pqid></control><display><type>article</type><title>HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Pimenta, Ana Teresa Mancini ; Correa, Isadora Alonso ; Melli, Patricia Pereira Dos Santos ; Abduch, Renata ; Duarte, Geraldo ; Couto-Fernandez, José Carlos ; Quintana, Silvana Maria</creator><creatorcontrib>Pimenta, Ana Teresa Mancini ; Correa, Isadora Alonso ; Melli, Patricia Pereira Dos Santos ; Abduch, Renata ; Duarte, Geraldo ; Couto-Fernandez, José Carlos ; Quintana, Silvana Maria</creatorcontrib><description>Increasing genetic diversity of HIV-1 and emergence of drug-resistant mutations may reduce the efficacy of antiretroviral therapy and prophylaxis that are used to prevent mother-to-child transmission. The aim of this study was to assess the genetic diversity and prevalence of drug-resistant mutations among HIV-infected pregnant women. Cross-sectional study at an outpatient clinic for infectious diseases within gynecology and obstetrics. This study evaluated the dynamics of HIV-1 subtypes and the prevalence of transmitted and acquired drug-resistant mutations among 38 HIV-infected pregnant women (20 previously exposed to antiretroviral therapy and 18 naive), in Ribeirão Preto (SP), Brazil, between 2010 and 2011. Genotyping was performed by means of molecular sequencing of the protease and reverse transcriptase regions of the HIV-1 pol gene. Subtype B was identified in 84.2% of the samples, recombinant forms between B and F in 7.9%, subtype F1 in 5.3% and the recombinant form K/F in 2.6%. No mutation associated with transmitted drug resistance was detected in the samples from the naive pregnant women, whereas mutations associated with acquired drug resistance were found in 35.0% of the pregnant women previously exposed to antiretroviral therapy. The results showed that subtype B predominated, while there was low prevalence of sequences with transmitted drug resistance.</description><identifier>ISSN: 1516-3180</identifier><identifier>ISSN: 1806-9460</identifier><identifier>EISSN: 1806-9460</identifier><identifier>DOI: 10.1590/1516-3180.2017.0233011017</identifier><identifier>PMID: 29791608</identifier><language>eng</language><publisher>Brazil: Associação Paulista de Medicina - APM</publisher><subject>Anti-HIV Agents - therapeutic use ; Cross-Sectional Studies ; Drug resistance ; Drug Resistance, Viral - genetics ; Female ; Genetic Variation ; Genotype ; HIV Infections - drug therapy ; HIV Infections - virology ; HIV-1 ; HIV-1 - drug effects ; HIV-1 - genetics ; Humans ; MEDICINE, GENERAL &amp; INTERNAL ; Mutation - genetics ; Phylogeny ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Pregnancy Complications, Infectious - virology ; Prevalence ; RNA, Viral - genetics ; Socioeconomic Factors</subject><ispartof>São Paulo medical journal, 2018-03, Vol.136 (2), p.129-135</ispartof><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3887-902cd4ac1528f545ea1618f1a3a2959ca75d63ec34044507eff449bb465c331e3</citedby><cites>FETCH-LOGICAL-c3887-902cd4ac1528f545ea1618f1a3a2959ca75d63ec34044507eff449bb465c331e3</cites><orcidid>0000-0003-2847-7102 ; 0000-0001-7091-9774 ; 0000-0002-9311-786X ; 0000-0002-1524-5292 ; 0000-0001-5383-7793 ; 0000-0002-1689-6142 ; 0000-0002-9248-8271</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,864,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29791608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pimenta, Ana Teresa Mancini</creatorcontrib><creatorcontrib>Correa, Isadora Alonso</creatorcontrib><creatorcontrib>Melli, Patricia Pereira Dos Santos</creatorcontrib><creatorcontrib>Abduch, Renata</creatorcontrib><creatorcontrib>Duarte, Geraldo</creatorcontrib><creatorcontrib>Couto-Fernandez, José Carlos</creatorcontrib><creatorcontrib>Quintana, Silvana Maria</creatorcontrib><title>HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study</title><title>São Paulo medical journal</title><addtitle>Sao Paulo Med J</addtitle><description>Increasing genetic diversity of HIV-1 and emergence of drug-resistant mutations may reduce the efficacy of antiretroviral therapy and prophylaxis that are used to prevent mother-to-child transmission. The aim of this study was to assess the genetic diversity and prevalence of drug-resistant mutations among HIV-infected pregnant women. Cross-sectional study at an outpatient clinic for infectious diseases within gynecology and obstetrics. This study evaluated the dynamics of HIV-1 subtypes and the prevalence of transmitted and acquired drug-resistant mutations among 38 HIV-infected pregnant women (20 previously exposed to antiretroviral therapy and 18 naive), in Ribeirão Preto (SP), Brazil, between 2010 and 2011. Genotyping was performed by means of molecular sequencing of the protease and reverse transcriptase regions of the HIV-1 pol gene. Subtype B was identified in 84.2% of the samples, recombinant forms between B and F in 7.9%, subtype F1 in 5.3% and the recombinant form K/F in 2.6%. No mutation associated with transmitted drug resistance was detected in the samples from the naive pregnant women, whereas mutations associated with acquired drug resistance were found in 35.0% of the pregnant women previously exposed to antiretroviral therapy. The results showed that subtype B predominated, while there was low prevalence of sequences with transmitted drug resistance.</description><subject>Anti-HIV Agents - therapeutic use</subject><subject>Cross-Sectional Studies</subject><subject>Drug resistance</subject><subject>Drug Resistance, Viral - genetics</subject><subject>Female</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>HIV-1</subject><subject>HIV-1 - drug effects</subject><subject>HIV-1 - genetics</subject><subject>Humans</subject><subject>MEDICINE, GENERAL &amp; INTERNAL</subject><subject>Mutation - genetics</subject><subject>Phylogeny</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Pregnancy Complications, Infectious - virology</subject><subject>Prevalence</subject><subject>RNA, Viral - genetics</subject><subject>Socioeconomic Factors</subject><issn>1516-3180</issn><issn>1806-9460</issn><issn>1806-9460</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNpFUltuFDEQHCEQCYErIPMXJGbxe-xPsiJkpUhEBPi1PHbPyqvZ8WLPBC1HyDU4ChfDwybLl1vlqmq7uqvqDcELIjR-TwSRNSMKLygmzQJTxjAhpXxSnRZU1ppL_LTUj7yT6kXOG4ypkoQ-r06objSRWJ1W91er7zVBaxhgDA75cAcph3GP7OBRghzyaAcHaIwFGUOCMcW7kGyPfJrWGdltHNZol2A9lHv0M25hQGFAX0ILIf35HdFN0UR0fnvz9h26SPZX6BdomWLOdQY3hjgUrzxOfv-yetbZPsOrh_Os-nb58evyqr7-_Gm1_HBdO6ZUU2tMnefWEUFVJ7gASyRRHbHMUi20s43wkoFjHHMucANdx7luWy6FY4wAO6tWB18f7cbsUtjatDfRBvMPiGltbCph9GBo17Sy4Up7X1p2jRKyE7T1vJNKKquL1-LglV2APppNnFL5UDa3c_Zmzr6MSOESPcaEzoLzg2CX4o8J8mi2ITvoeztAnLKhmLOGSM5IoeoD1c1pJeiObyXYzHtgjj3MvAfm_x4U7euHNlO7BX9UPg6e_QXzRqv-</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Pimenta, Ana Teresa Mancini</creator><creator>Correa, Isadora Alonso</creator><creator>Melli, Patricia Pereira Dos Santos</creator><creator>Abduch, Renata</creator><creator>Duarte, Geraldo</creator><creator>Couto-Fernandez, José Carlos</creator><creator>Quintana, Silvana Maria</creator><general>Associação Paulista de Medicina - APM</general><general>Associação Paulista de Medicina</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>GPN</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2847-7102</orcidid><orcidid>https://orcid.org/0000-0001-7091-9774</orcidid><orcidid>https://orcid.org/0000-0002-9311-786X</orcidid><orcidid>https://orcid.org/0000-0002-1524-5292</orcidid><orcidid>https://orcid.org/0000-0001-5383-7793</orcidid><orcidid>https://orcid.org/0000-0002-1689-6142</orcidid><orcidid>https://orcid.org/0000-0002-9248-8271</orcidid></search><sort><creationdate>201803</creationdate><title>HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study</title><author>Pimenta, Ana Teresa Mancini ; Correa, Isadora Alonso ; Melli, Patricia Pereira Dos Santos ; Abduch, Renata ; Duarte, Geraldo ; Couto-Fernandez, José Carlos ; Quintana, Silvana Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3887-902cd4ac1528f545ea1618f1a3a2959ca75d63ec34044507eff449bb465c331e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-HIV Agents - therapeutic use</topic><topic>Cross-Sectional Studies</topic><topic>Drug resistance</topic><topic>Drug Resistance, Viral - genetics</topic><topic>Female</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>HIV-1</topic><topic>HIV-1 - drug effects</topic><topic>HIV-1 - genetics</topic><topic>Humans</topic><topic>MEDICINE, GENERAL &amp; INTERNAL</topic><topic>Mutation - genetics</topic><topic>Phylogeny</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Pregnancy Complications, Infectious - virology</topic><topic>Prevalence</topic><topic>RNA, Viral - genetics</topic><topic>Socioeconomic Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pimenta, Ana Teresa Mancini</creatorcontrib><creatorcontrib>Correa, Isadora Alonso</creatorcontrib><creatorcontrib>Melli, Patricia Pereira Dos Santos</creatorcontrib><creatorcontrib>Abduch, Renata</creatorcontrib><creatorcontrib>Duarte, Geraldo</creatorcontrib><creatorcontrib>Couto-Fernandez, José Carlos</creatorcontrib><creatorcontrib>Quintana, Silvana Maria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SciELO</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>São Paulo medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pimenta, Ana Teresa Mancini</au><au>Correa, Isadora Alonso</au><au>Melli, Patricia Pereira Dos Santos</au><au>Abduch, Renata</au><au>Duarte, Geraldo</au><au>Couto-Fernandez, José Carlos</au><au>Quintana, Silvana Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study</atitle><jtitle>São Paulo medical journal</jtitle><addtitle>Sao Paulo Med J</addtitle><date>2018-03</date><risdate>2018</risdate><volume>136</volume><issue>2</issue><spage>129</spage><epage>135</epage><pages>129-135</pages><issn>1516-3180</issn><issn>1806-9460</issn><eissn>1806-9460</eissn><abstract>Increasing genetic diversity of HIV-1 and emergence of drug-resistant mutations may reduce the efficacy of antiretroviral therapy and prophylaxis that are used to prevent mother-to-child transmission. The aim of this study was to assess the genetic diversity and prevalence of drug-resistant mutations among HIV-infected pregnant women. Cross-sectional study at an outpatient clinic for infectious diseases within gynecology and obstetrics. This study evaluated the dynamics of HIV-1 subtypes and the prevalence of transmitted and acquired drug-resistant mutations among 38 HIV-infected pregnant women (20 previously exposed to antiretroviral therapy and 18 naive), in Ribeirão Preto (SP), Brazil, between 2010 and 2011. Genotyping was performed by means of molecular sequencing of the protease and reverse transcriptase regions of the HIV-1 pol gene. Subtype B was identified in 84.2% of the samples, recombinant forms between B and F in 7.9%, subtype F1 in 5.3% and the recombinant form K/F in 2.6%. No mutation associated with transmitted drug resistance was detected in the samples from the naive pregnant women, whereas mutations associated with acquired drug resistance were found in 35.0% of the pregnant women previously exposed to antiretroviral therapy. The results showed that subtype B predominated, while there was low prevalence of sequences with transmitted drug resistance.</abstract><cop>Brazil</cop><pub>Associação Paulista de Medicina - APM</pub><pmid>29791608</pmid><doi>10.1590/1516-3180.2017.0233011017</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2847-7102</orcidid><orcidid>https://orcid.org/0000-0001-7091-9774</orcidid><orcidid>https://orcid.org/0000-0002-9311-786X</orcidid><orcidid>https://orcid.org/0000-0002-1524-5292</orcidid><orcidid>https://orcid.org/0000-0001-5383-7793</orcidid><orcidid>https://orcid.org/0000-0002-1689-6142</orcidid><orcidid>https://orcid.org/0000-0002-9248-8271</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1516-3180
ispartof São Paulo medical journal, 2018-03, Vol.136 (2), p.129-135
issn 1516-3180
1806-9460
1806-9460
language eng
recordid cdi_scielo_journals_S1516_31802018000200129
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Anti-HIV Agents - therapeutic use
Cross-Sectional Studies
Drug resistance
Drug Resistance, Viral - genetics
Female
Genetic Variation
Genotype
HIV Infections - drug therapy
HIV Infections - virology
HIV-1
HIV-1 - drug effects
HIV-1 - genetics
Humans
MEDICINE, GENERAL & INTERNAL
Mutation - genetics
Phylogeny
Pregnancy
Pregnancy Complications, Infectious - drug therapy
Pregnancy Complications, Infectious - virology
Prevalence
RNA, Viral - genetics
Socioeconomic Factors
title HIV-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in Ribeirão Preto (SP), Brazil. Cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV-1%20genetic%20diversity%20and%20resistance%20to%20antiretroviral%20drugs%20among%20pregnant%20women%20in%20Ribeir%C3%A3o%20Preto%20(SP),%20Brazil.%20Cross-sectional%20study&rft.jtitle=S%C3%A3o%20Paulo%20medical%20journal&rft.au=Pimenta,%20Ana%20Teresa%20Mancini&rft.date=2018-03&rft.volume=136&rft.issue=2&rft.spage=129&rft.epage=135&rft.pages=129-135&rft.issn=1516-3180&rft.eissn=1806-9460&rft_id=info:doi/10.1590/1516-3180.2017.0233011017&rft_dat=%3Cproquest_doaj_%3E2043716431%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2043716431&rft_id=info:pmid/29791608&rft_scielo_id=S1516_31802018000200129&rft_doaj_id=oai_doaj_org_article_2f7b67489ddd4af7856f52bd4f6868a9&rfr_iscdi=true